Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06436794
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-31
First Post:
2024-04-16
Brief Title:
Mantou Screening for GDM Before 20 Weeks of Gestation
Sponsor:
Jiang Ziyan
Organization:
The First Affiliated Hospital with Nanjing Medical University
Study Overview
Official Title:
Mantou Screening for Gestational Diabetes Mellitus Before 20 Weeks of GestationA ProspectiveMulticenter Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Gestational diabetes mellitus GDM can occur in overweight hyperinsulinemia insulin resistance pregnant women or lean insulin deficiency pregnant women At least 5 of all pregnant women will develop GDM which is even higher among Asians Poor control of GDM in late pregnancy will increase the following risks macrosomia preeclampsia shoulder dystocia cesarean section stillbirth and other risks At present the screening method for GDM is 75g of glucose OGTT test However when drinking sugared water on an empty stomach the pregnant women will feel nausea stomach burning and hunger when waiting for blood drawing Some women vomit after drinking sugared water resulting in inaccurate test results and poor compliance affecting the accuracy of diagnosis of GDM Sugar tolerance Mantou has been used for screening diabetes since 1982 It is made of 100g flour and contains 75g glucose of the same amount It is a feasible method to use Mantou instead of sugar powder to screen GDM Mantou is an acceptable diet for Chinese people which greatly reduces nausea vomiting hunger and other discomfort and increases GDM screening rate At present the cesarean section rate in China remains high and the weight and nutritional management of pregnant women are not satisfied Many pregnant women especially those in country-level areas have already gained excessive weight when referred from to delivery hospitals leading to an increase in pregnancy complications such as preeclampsia and macrosomia increasing the cesarean section rate and delivery risk Therefore it is necessary to screen GDM in advance Moving forward the screening of GDM and strengthening the management of pregnant womens weight can effectively reduce the occurrence of pregnancy complications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None